SELUTION 4 De Novo Small Vessel IDE Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 960 participants.
Also called NCT05946629
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 960 participants
- Registry
-
NCT05946629
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Belgium, Germany
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05946629. Randomized; double masking; primary purpose treatment. Start 2023-10-20 (actual); primary completion 2027-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- SELUTION 4 De Novo Small Vessel IDE Trial
- Condition
- Coronary Artery Disease
- Intervention (Device)
- PCI (percutaneous coronary intervention) with SELUTION SLR DCB
- Intervention (Device)
- PCI with FDA approved "-limus" DES
- Lead sponsor
- M.A. Med Alliance S.A.
- Collaborator
- NAMSA
- Collaborator
- Cordis US Corp.
Record details
- Record id
cardio:ct-nct05946629- Content hash
a270c86d69d83e93438ee04d4f7ad08b8042a77499fe38b57945a09ef41a0a29